Contraindications BYETTA is contraindicated in patients with: A prior severe hypersensitivity reaction to exenatide or to any of the excipients in BYETTA
Selected relationships of particular clinical significance were additionally presented graphically using forest plots
It plays a role in cellular energy production, cellular repair processes, and serves as a cofactor in multiple enzymatic reactions
Since its isolation and characterisation in the early 1990s, it has become one of the most extensively studied peptides in regenerative biology research, with a broad research profile spanning gastrointestinal, musculoskeletal, vascular, and neurological tissue models
Medications such as Ozempic, Rybelsus, and Victoza typically have better coverage than Wegovy or Saxenda